Form 4: Enfusion CEO Oleg Movchan Sells Shares to Cover Tax Obligations

Sentiment:

SEC Form 4 Filing


Enfusion's CEO, Oleg Movchan, sold shares of Class A Common Stock on January 7, 2025, to cover tax withholding obligations.

Summary

  • Oleg Movchan, CEO of Enfusion, Inc., reported changes in beneficial ownership of the company's stock.
  • On January 7, 2025, Movchan sold 2,771 shares of Class A Common Stock at a price of $10.13 per share.
  • The sale was required by the Issuer to cover tax withholding obligations related to the issuance of shares.
  • Following the transaction, Movchan directly owns 526,702 shares of Class A Common Stock.
  • Movchan also indirectly owns 1,151,818 shares through CSL Tech Holdings, LLC, where he serves as manager.
  • Movchan disclaims beneficial ownership of the shares held by CSL Tech Holdings, LLC, except to the extent of his pecuniary interest.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing related to stock transactions by an insider. The sale is attributed to tax obligations, suggesting a neutral sentiment.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This sale appears to be related to tax obligations, which is a common occurrence.

Stakeholder Impact

  • The sale of shares by the CEO could have a minor impact on shareholder sentiment, but is unlikely to be significant given the stated reason for the sale.

Key Dates

DateDescription
01/07/2025Date of the stock sale transaction.
01/10/2025Date of signature for the Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.